pathwayRes	pathway	pathwayTitle	TotalMetabolitesinPW	BiomarkersInPWs	probabilities
<https://identifiers.org/wikipathways/WP3604_r117661>	WP3604	Biochemical pathways: part I	470	88	8.11897536895585e-148
<https://identifiers.org/wikipathways/WP3925_r117062>	WP3925	Amino acid metabolism	108	34	4.39618304934461e-63
<https://identifiers.org/wikipathways/WP15_r121694>	WP15	Selenium micronutrient network	110	21	5.70730409453658e-81
<https://identifiers.org/wikipathways/WP661_r117736>	WP661	Glucose homeostasis	21	18	9.43216922871807e-05
<https://identifiers.org/wikipathways/WP3602_r116568>	WP3602	Metabolism overview	115	14	1.18539441676033e-94
<https://identifiers.org/wikipathways/WP4224_r120400>	WP4224	Purine metabolism and related disorders	61	14	3.80185878739389e-53
<https://identifiers.org/wikipathways/WP2525_r116582>	WP2525	Trans-sulfuration and one-carbon metabolism	34	13	9.99721920164539e-28
<https://identifiers.org/wikipathways/WP497_r119105>	WP497	Urea cycle and metabolism of amino groups	31	13	2.65755890923606e-24
<https://identifiers.org/wikipathways/WP4726_r120323>	WP4726	Sphingolipid metabolism: integrated pathway	67	12	1.53332194896442e-61
<https://identifiers.org/wikipathways/WP3580_r120915>	WP3580	Methionine de novo and salvage pathway	50	12	5.6072787200604e-46
<https://identifiers.org/wikipathways/WP3940_r119248>	WP3940	One-carbon metabolism and related pathways	41	12	7.0345387860641e-37
<https://identifiers.org/wikipathways/WP550_r119093>	WP550	Biogenic amine synthesis	17	11	1.21971089978646e-09
<https://identifiers.org/wikipathways/WP4686_r122622>	WP4686	Leucine, isoleucine and valine metabolism	74	10	9.92325156249378e-71
<https://identifiers.org/wikipathways/WP4022_r120306>	WP4022	Pyrimidine metabolism	40	10	4.84963242158281e-39
<https://identifiers.org/wikipathways/WP4583_r106803>	WP4583	Biomarkers for urea cycle disorders	22	10	5.3510369434338e-18
<https://identifiers.org/wikipathways/WP176_r121696>	WP176	Folate metabolism	70	9	4.49176319269534e-69
<https://identifiers.org/wikipathways/WP1533_r121695>	WP1533	Vitamin B12 metabolism	63	9	5.41327783360013e-63
<https://identifiers.org/wikipathways/WP4792_r119117>	WP4792	Purine metabolism	37	9	1.78034194812704e-37
<https://identifiers.org/wikipathways/WP4723_r120315>	WP4723	Omega-3 / omega-6 fatty acid synthesis	38	8	2.79786485860544e-40
<https://identifiers.org/wikipathways/WP4724_r117812>	WP4724	Omega-9 fatty acid synthesis	27	8	1.19189740068569e-27
<https://identifiers.org/wikipathways/WP4485_r119318>	WP4485	Modified nucleosides derived from tRNA as urinary cancer markers	19	8	2.34020998792381e-17
<https://identifiers.org/wikipathways/WP3953_r106206>	WP3953	mRNA, protein, and metabolite inducation pathway by cyclosporin A	14	8	2.95959262448184e-10
<https://identifiers.org/wikipathways/WP4238_r120817>	WP4238	Flavan-3-ol metabolic pathway	65	7	2.73364411718869e-68
<https://identifiers.org/wikipathways/WP4504_r119316>	WP4504	Cysteine and methionine catabolism	39	7	3.9770644756297e-43
<https://identifiers.org/wikipathways/WP4225_r120401>	WP4225	Pyrimidine metabolism and related diseases	37	7	5.89024180759054e-41
<https://identifiers.org/wikipathways/WP4584_r119306>	WP4584	Biomarkers for pyrimidine metabolism disorders	35	7	9.62346998987577e-39
<https://identifiers.org/wikipathways/WP4595_r121755>	WP4595	Urea cycle and associated pathways	30	7	5.25598295703732e-33
<https://identifiers.org/wikipathways/WP241_r120901>	WP241	One-carbon metabolism	25	7	6.19379162065727e-27
<https://identifiers.org/wikipathways/WP4210_r95880>	WP4210	Tryptophan catabolism leading to NAD+ production	23	7	2.13241922513195e-24
<https://identifiers.org/wikipathways/WP4661_r117646>	WP4661	Amino acid metabolism pathway excerpt: histidine catabolism extension	16	7	6.44844982926274e-15
<https://identifiers.org/wikipathways/WP706_r117178>	WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	14	7	5.3325993233907e-12
<https://identifiers.org/wikipathways/WP465_r122957>	WP465	Tryptophan metabolism	63	6	2.27694155434099e-68
<https://identifiers.org/wikipathways/WP4259_r119256>	WP4259	Disorders of folate metabolism and transport	26	6	5.4093730803468e-30
<https://identifiers.org/wikipathways/WP4292_r121757>	WP4292	Methionine metabolism leading to sulfur amino acids and related disorders	23	6	3.28787105196555e-26
<https://identifiers.org/wikipathways/WP106_r114258>	WP106	Alanine and aspartate metabolism	22	6	6.48997155474942e-25
<https://identifiers.org/wikipathways/WP4156_r121756>	WP4156	Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine	22	6	6.48997155474942e-25
<https://identifiers.org/wikipathways/WP4195_r101838>	WP4195	Phosphatidylcholine catabolism	20	6	2.87632167892697e-22
<https://identifiers.org/wikipathways/WP5176_r122283>	WP5176	Disorders of bile acid synthesis and biliary transport	44	5	4.10984444313142e-52
<https://identifiers.org/wikipathways/WP4949_r115778>	WP4949	16p11.2 proximal deletion syndrome	42	5	4.91139444287537e-50
<https://identifiers.org/wikipathways/WP2289_r120498>	WP2289	Drug induction of bile acid pathway	27	5	4.16853820730543e-33
<https://identifiers.org/wikipathways/WP1422_r118359>	WP1422	Sphingolipid pathway	26	5	7.08651495241933e-32
<https://identifiers.org/wikipathways/WP4288_r120407>	WP4288	MTHFR deficiency	23	5	4.33565413446006e-28
<https://identifiers.org/wikipathways/WP3996_r107156>	WP3996	Ethanol effects on histone modifications	21	5	1.76999224220438e-25
<https://identifiers.org/wikipathways/WP4228_r119281>	WP4228	Vitamin B6-dependent and responsive disorders	19	5	8.62896503678103e-23
<https://identifiers.org/wikipathways/WP4220_r120526>	WP4220	Neurotransmitter disorders	18	5	2.04824380609906e-21
<https://identifiers.org/wikipathways/WP4853_r122756>	WP4853	Linoleic acid metabolism affected by SARS-CoV-2	14	5	1.12847872012098e-15
<https://identifiers.org/wikipathways/WP4313_r120500>	WP4313	Ferroptosis	38	4	9.67383229935547e-48
<https://identifiers.org/wikipathways/WP4290_r118611>	WP4290	Metabolic reprogramming in colon cancer	37	4	1.19904605605168e-46
<https://identifiers.org/wikipathways/WP4657_r120007>	WP4657	22q11.2 copy number variation syndrome	31	4	7.47813092461952e-40
<https://identifiers.org/wikipathways/WP4519_r119988>	WP4519	Cerebral organic acidurias, including diseases	28	4	2.7520293738695e-36
<https://identifiers.org/wikipathways/WP2485_r117161>	WP2485	NAD biosynthesis II (from tryptophan)	25	4	1.36279133700373e-32
<https://identifiers.org/wikipathways/WP78_r119082>	WP78	TCA cycle (aka Krebs or citric acid cycle)	24	4	2.4966337293908e-31
<https://identifiers.org/wikipathways/WP4586_r119267>	WP4586	Metabolism of alpha-linolenic acid	20	4	4.21426724334375e-26
<https://identifiers.org/wikipathways/WP2453_r117835>	WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	19	4	9.54531530617366e-25
<https://identifiers.org/wikipathways/WP4932_r118797>	WP4932	7q11.23 copy number variation syndrome	19	4	9.54531530617366e-25
<https://identifiers.org/wikipathways/WP4506_r120405>	WP4506	Tyrosine metabolism	18	4	2.27078027283707e-23
<https://identifiers.org/wikipathways/WP5190_r122630>	WP5190	Creatine pathway	18	4	2.27078027283707e-23
<https://identifiers.org/wikipathways/WP5166_r122169>	WP5166	Glyoxylate metabolism	16	4	1.50606162213166e-20
<https://identifiers.org/wikipathways/WP3644_r118983>	WP3644	NAD+ metabolism	15	4	4.22638542710695e-19
<https://identifiers.org/wikipathways/WP2333_r72015>	WP2333	Trans-sulfuration pathway	14	4	1.26228044756261e-17
<https://identifiers.org/wikipathways/WP4486_r119317>	WP4486	Role of carnosine in muscle contraction	11	4	5.12749934941415e-13
<https://identifiers.org/wikipathways/WP58_r113950>	WP58	Monoamine GPCRs	7	4	2.48214979703107e-06
<https://identifiers.org/wikipathways/WP2533_r120261>	WP2533	Glycerophospholipid biosynthetic pathway	58	3	7.88935795625247e-70
<https://identifiers.org/wikipathways/WP4900_r110333>	WP4900	Purinergic signaling	56	3	5.7648154271261e-68
<https://identifiers.org/wikipathways/WP4545_r121824>	WP4545	Oxysterols derived from cholesterol	51	3	3.48058071112752e-63
<https://identifiers.org/wikipathways/WP4718_r119764>	WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	46	3	3.24565757609248e-58
<https://identifiers.org/wikipathways/WP2436_r107129>	WP2436	Dopamine metabolism	34	3	2.26774536366772e-45
<https://identifiers.org/wikipathways/WP4523_r121849>	WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	30	3	9.64920119305749e-41
<https://identifiers.org/wikipathways/WP5083_r120385>	WP5083	Neuroinflammation and glutamatergic signaling	27	3	3.93147053409931e-37
<https://identifiers.org/wikipathways/WP5224_r122740>	WP5224	2q37 copy number variation syndrome	27	3	3.93147053409931e-37
<https://identifiers.org/wikipathways/WP4725_r117175>	WP4725	Sphingolipid metabolism overview	26	3	6.71262191192505e-36
<https://identifiers.org/wikipathways/WP4157_r120415>	WP4157	GABA metabolism (aka GHB)	21	3	1.71369728634785e-29
<https://identifiers.org/wikipathways/WP4236_r120410>	WP4236	Krebs cycle disorders	21	3	1.71369728634785e-29
<https://identifiers.org/wikipathways/WP3933_r116372>	WP3933	Kennedy pathway from sphingolipids	20	3	3.71301078708703e-28
<https://identifiers.org/wikipathways/WP5169_r122351>	WP5169	Hemesynthesis defects and porphyrias	18	3	2.0095400644576e-25
<https://identifiers.org/wikipathways/WP5213_r122577>	WP5213	Amino acid metabolism in triple-negative breast cancer cells	18	3	2.0095400644576e-25
<https://identifiers.org/wikipathways/WP534_r117147>	WP534	Glycolysis and gluconeogenesis	18	3	2.0095400644576e-25
<https://identifiers.org/wikipathways/WP4008_r117805>	WP4008	NO/cGMP/PKG mediated neuroprotection	15	3	3.76515405532915e-21
<https://identifiers.org/wikipathways/WP2197_r117710>	WP2197	Endothelin pathways	14	3	1.12703611389519e-19
<https://identifiers.org/wikipathways/WP3645_r118940>	WP3645	NAD+ biosynthetic pathways	14	3	1.12703611389519e-19
<https://identifiers.org/wikipathways/WP4571_r120383>	WP4571	Urea cycle and related diseases	14	3	1.12703611389519e-19
<https://identifiers.org/wikipathways/WP727_r116775>	WP727	Monoamine transport	14	3	1.12703611389519e-19
<https://identifiers.org/wikipathways/WP1495_r117738>	WP1495	Glycine metabolism	13	3	3.60651556446461e-18
<https://identifiers.org/wikipathways/WP2848_r120814>	WP2848	Pluripotent stem cell differentiation pathway	13	3	3.60651556446461e-18
<https://identifiers.org/wikipathways/WP3584_r117155>	WP3584	MECP2 and associated Rett syndrome	11	3	4.60898817924869e-15
<https://identifiers.org/wikipathways/WP3633_r118462>	WP3633	Caffeine and theobromine metabolism	11	3	4.60898817924869e-15
<https://identifiers.org/wikipathways/WP2456_r119185>	WP2456	HIF1A and PPARG regulation of glycolysis	10	3	1.86454521796879e-13
<https://identifiers.org/wikipathways/WP528_r120525>	WP528	Acetylcholine synthesis	10	3	1.86454521796879e-13
<https://identifiers.org/wikipathways/WP1995_r116455>	WP1995	Effects of nitric oxide	7	3	2.25138303585585e-08
<https://identifiers.org/wikipathways/WP715_r106831>	WP715	Amino acid conjugation	6	3	1.41837131258918e-06
<https://identifiers.org/wikipathways/WP1982_r116442>	WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	5	3	0.00010401389625654
<https://identifiers.org/wikipathways/WP4142_r119292>	WP4142	Metabolism of spingolipids in ER and Golgi apparatus	37	2	6.47223392017532e-51
<https://identifiers.org/wikipathways/WP4722_r117144>	WP4722	Glycerolipids and glycerophospholipids	29	2	9.64920119305738e-42
<https://identifiers.org/wikipathways/WP4688_r120418>	WP4688	Serine metabolism	26	2	4.36830059344362e-38
<https://identifiers.org/wikipathways/WP5044_r119244>	WP5044	Kynurenine pathway and links to cell senescence	26	2	4.36830059344362e-38
<https://identifiers.org/wikipathways/WP5194_r122165>	WP5194	Synthesis of ceramides and 1-deoxyceramides	24	2	1.42514126745486e-35
<https://identifiers.org/wikipathways/WP3869_r118463>	WP3869	Cannabinoid receptor signaling	22	2	5.42746462911039e-33
<https://identifiers.org/wikipathways/WP5122_r119484>	WP5122	Prostaglandin and leukotriene metabolism in senescence 	22	2	5.42746462911039e-33
<https://identifiers.org/wikipathways/WP4629_r119264>	WP4629	Aerobic glycolysis	20	2	2.44813898049695e-30
<https://identifiers.org/wikipathways/WP100_r107114>	WP100	Glutathione metabolism	19	2	5.56951618063052e-29
<https://identifiers.org/wikipathways/WP561_r117151>	WP561	Heme biosynthesis	18	2	1.33082123474013e-27
<https://identifiers.org/wikipathways/WP430_r122069>	WP430	Statin inhibition of cholesterol production	17	2	3.34923344076266e-26
<https://identifiers.org/wikipathways/WP4969_r120081>	WP4969	RAS and bradykinin pathways in COVID-19	17	2	3.34923344076266e-26
<https://identifiers.org/wikipathways/WP5137_r120230>	WP5137	Linoleic acid oxylipin metabolism	14	2	7.53030811065826e-22
<https://identifiers.org/wikipathways/WP98_r117172>	WP98	Prostaglandin synthesis and regulation	13	2	2.41507738691826e-20
<https://identifiers.org/wikipathways/WP2447_r113794>	WP2447	Amyotrophic lateral sclerosis (ALS)	12	2	8.32272822568765e-19
<https://identifiers.org/wikipathways/WP4222_r107160>	WP4222	Phosphodiesterases in neuronal function	12	2	8.32272822568765e-19
<https://identifiers.org/wikipathways/WP4756_r120634>	WP4756	Renin-angiotensin-aldosterone system (RAAS)	12	2	8.32272822568765e-19
<https://identifiers.org/wikipathways/WP5046_r118987>	WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	12	2	8.32272822568765e-19
<https://identifiers.org/wikipathways/WP1600_r119518>	WP1600	Nicotine metabolism in liver cells	11	2	3.10021626406862e-17
<https://identifiers.org/wikipathways/WP4507_r119314>	WP4507	Molybdenum cofactor (Moco) biosynthesis	11	2	3.10021626406862e-17
<https://identifiers.org/wikipathways/WP4919_r111814>	WP4919	Neuroinflammation	11	2	3.10021626406862e-17
<https://identifiers.org/wikipathways/WP690_r117170>	WP690	Polyol pathway	11	2	3.10021626406862e-17
<https://identifiers.org/wikipathways/WP521_r111034>	WP521	Amino acid conjugation of benzoic acid	10	2	1.25699677615873e-15
<https://identifiers.org/wikipathways/WP2597_r117821>	WP2597	Secretion of hydrochloric acid in parietal cells	9	2	5.59363565390635e-14
<https://identifiers.org/wikipathways/WP455_r117740>	WP455	GPCRs, class A rhodopsin-like	9	2	5.59363565390635e-14
<https://identifiers.org/wikipathways/WP4947_r118070>	WP4947	Nitric oxide metabolism in cystic fibrosis	9	2	5.59363565390635e-14
<https://identifiers.org/wikipathways/WP1403_r121114>	WP1403	AMP-activated protein kinase (AMPK) signaling	7	2	1.52808803338631e-10
<https://identifiers.org/wikipathways/WP2267_r117179>	WP2267	Synaptic vesicle pathway	7	2	1.52808803338631e-10
<https://identifiers.org/wikipathways/WP5181_r122326>	WP5181	Roles of ceramides in the development of insulin resistance	7	2	1.52808803338631e-10
<https://identifiers.org/wikipathways/WP2596_r122782>	WP2596	Gastric acid production	6	2	9.64878443938222e-09
<https://identifiers.org/wikipathways/WP4846_r122702>	WP4846	SARS-CoV-2 and COVID-19 pathway	5	2	7.09185656294591e-07
<https://identifiers.org/wikipathways/WP704_r117787>	WP704	Methylation pathways	5	2	7.09185656294591e-07
<https://identifiers.org/wikipathways/WP2868_r117183>	WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	4	2	6.24083377539239e-05
<https://identifiers.org/wikipathways/WP4495_r117759>	WP4495	IL-10 anti-inflammatory signaling pathway 	4	2	6.24083377539239e-05
<https://identifiers.org/wikipathways/WP1455_r117827>	WP1455	Serotonin transporter activity	3	2	0.00684931506849311
<https://identifiers.org/wikipathways/WP80_r111167>	WP80	Nucleotide GPCRs	2	2	1
<https://identifiers.org/wikipathways/WP4721_r116526>	WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	40	1	1.51374370838203e-56
<https://identifiers.org/wikipathways/WP4719_r116307>	WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	37	1	2.73667396201917e-53
<https://identifiers.org/wikipathways/WP143_r116506>	WP143	Fatty acid beta-oxidation	35	1	4.58692854402816e-51
<https://identifiers.org/wikipathways/WP5220_r122761>	WP5220	Metabolic reprogramming in pancreatic cancer	32	1	1.21269805543728e-47
<https://identifiers.org/wikipathways/WP4521_r119311>	WP4521	Glycosylation and related congenital defects	29	1	4.15019406153004e-44
<https://identifiers.org/wikipathways/WP1946_r122878>	WP1946	Cori cycle	28	1	6.65462151245333e-43
<https://identifiers.org/wikipathways/WP4917_r119111>	WP4917	Proximal tubule transport	28	1	6.65462151245333e-43
<https://identifiers.org/wikipathways/WP167_r120547>	WP167	Eicosanoid synthesis	27	1	1.10276585063514e-41
<https://identifiers.org/wikipathways/WP5037_r120417>	WP5037	Riboflavin and CoQ disorders	27	1	1.10276585063514e-41
<https://identifiers.org/wikipathways/WP5064_r120384>	WP5064	7-oxo-C and 7-beta-HC pathways	27	1	1.10276585063514e-41
<https://identifiers.org/wikipathways/WP4321_r106178>	WP4321	Thermogenesis	26	1	1.89103921794099e-40
<https://identifiers.org/wikipathways/WP4577_r118444>	WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	23	1	1.18761772287905e-36
<https://identifiers.org/wikipathways/WP4838_r110282>	WP4838	Regucalcin in proximal tubule epithelial kidney cells	23	1	1.18761772287905e-36
<https://identifiers.org/wikipathways/WP4297_r120409>	WP4297	Thiamine metabolic pathways	21	1	4.93405875373678e-34
<https://identifiers.org/wikipathways/WP1601_r120496>	WP1601	Fluoropyrimidine activity	20	1	1.07374516688461e-32
<https://identifiers.org/wikipathways/WP5179_r121899>	WP5179	Biosynthesis and turnover of 1-deoxy-sphingoid bases	20	1	1.07374516688461e-32
<https://identifiers.org/wikipathways/WP4153_r120394>	WP4153	Degradation pathway of sphingolipids, including diseases	19	1	2.44813898049693e-31
<https://identifiers.org/wikipathways/WP4271_r120408>	WP4271	Vitamin B12 disorders	19	1	2.44813898049693e-31
<https://identifiers.org/wikipathways/WP5171_r122629>	WP5171	Leukotriene metabolic pathway	19	1	2.44813898049693e-31
<https://identifiers.org/wikipathways/WP3298_r120642>	WP3298	Melatonin metabolism and effects	18	1	5.86264861119002e-30
<https://identifiers.org/wikipathways/WP4524_r119308>	WP4524	Alternative pathway of fetal androgen synthesis	18	1	5.86264861119002e-30
<https://identifiers.org/wikipathways/WP4269_r117715>	WP4269	Ethanol metabolism production of ROS by CYP2E1	17	1	1.47869026082237e-28
<https://identifiers.org/wikipathways/WP5193_r122440>	WP5193	Cholesterol synthesis disorders	17	1	1.47869026082237e-28
<https://identifiers.org/wikipathways/WP4698_r119119>	WP4698	Vitamin D-sensitive calcium signaling in depression	16	1	3.94027463619138e-27
<https://identifiers.org/wikipathways/WP4906_r115773>	WP4906	3q29 copy number variation syndrome	16	1	3.94027463619138e-27
<https://identifiers.org/wikipathways/WP197_r120482>	WP197	Cholesterol biosynthesis pathway	15	1	1.11312758472406e-25
<https://identifiers.org/wikipathways/WP4804_r117680>	WP4804	Cholesterol biosynthesis with skeletal dysplasias	15	1	1.11312758472406e-25
<https://identifiers.org/wikipathways/WP5031_r122564>	WP5031	Biotin metabolism, including IMDs	15	1	1.11312758472406e-25
<https://identifiers.org/wikipathways/WP4941_r120578>	WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	14	1	3.34680360473701e-24
<https://identifiers.org/wikipathways/WP5050_r119012>	WP5050	TCA cycle in senescence	14	1	3.34680360473701e-24
<https://identifiers.org/wikipathways/WP5121_r119472>	WP5121	Sphingolipid metabolism in senescence	14	1	3.34680360473701e-24
<https://identifiers.org/wikipathways/WP536_r116854>	WP536	Calcium regulation in cardiac cells	14	1	3.34680360473701e-24
<https://identifiers.org/wikipathways/WP698_r106827>	WP698	Glucuronidation	14	1	3.34680360473701e-24
<https://identifiers.org/wikipathways/WP1589_r122870>	WP1589	Folate-alcohol and cancer pathway hypotheses	13	1	1.07575830152261e-22
<https://identifiers.org/wikipathways/WP3965_r117154>	WP3965	Lipid metabolism pathway	13	1	1.07575830152261e-22
<https://identifiers.org/wikipathways/WP4720_r120365>	WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	13	1	1.07575830152261e-22
<https://identifiers.org/wikipathways/WP5087_r122659>	WP5087	Malignant pleural mesothelioma	13	1	1.07575830152261e-22
<https://identifiers.org/wikipathways/WP5136_r120082>	WP5136	ALA oxylipin metabolism	13	1	1.07575830152261e-22
<https://identifiers.org/wikipathways/WP5175_r122904>	WP5175	Disorders in ketone body synthesis	13	1	1.07575830152261e-22
<https://identifiers.org/wikipathways/WP111_r117097>	WP111	Electron transport chain: OXPHOS system in mitochondria	12	1	3.71550367218199e-21
<https://identifiers.org/wikipathways/WP299_r117807>	WP299	Nuclear receptors in lipid metabolism and toxicity	12	1	3.71550367218199e-21
<https://identifiers.org/wikipathways/WP496_r119106>	WP496	Steroid biosynthesis	12	1	3.71550367218199e-21
<https://identifiers.org/wikipathways/WP325_r116669>	WP325	Triacylglyceride synthesis	11	1	1.38712137094793e-19
<https://identifiers.org/wikipathways/WP3963_r107557>	WP3963	Mevalonate pathway	11	1	1.38712137094793e-19
<https://identifiers.org/wikipathways/WP4255_r119279>	WP4255	Non-small cell lung cancer	11	1	1.38712137094793e-19
<https://identifiers.org/wikipathways/WP4304_r119229>	WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	11	1	1.38712137094793e-19
<https://identifiers.org/wikipathways/WP4518_r122628>	WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases	11	1	1.38712137094793e-19
<https://identifiers.org/wikipathways/WP4580_r119307>	WP4580	Blood clotting and drug effects	11	1	1.38712137094793e-19
<https://identifiers.org/wikipathways/WP5111_r119173>	WP5111	Familial hyperlipidemia type 4	11	1	1.38712137094793e-19
<https://identifiers.org/wikipathways/WP2526_r121697>	WP2526	PDGF pathway	10	1	5.63675684376111e-18
<https://identifiers.org/wikipathways/WP3601_r117687>	WP3601	Lipid particles composition	10	1	5.63675684376111e-18
<https://identifiers.org/wikipathways/WP3891_r106161>	WP3891	Benzene metabolism	10	1	5.63675684376111e-18
<https://identifiers.org/wikipathways/WP3915_r122574>	WP3915	Angiopoietin-like protein 8 regulatory pathway	10	1	5.63675684376111e-18
<https://identifiers.org/wikipathways/WP4159_r119288>	WP4159	GABA receptor signaling	10	1	5.63675684376111e-18
<https://identifiers.org/wikipathways/WP5108_r120390>	WP5108	Familial  hyperlipidemia type 1	10	1	5.63675684376111e-18
<https://identifiers.org/wikipathways/WP5109_r120391>	WP5109	Familial hyperlipidemia type 2	10	1	5.63675684376111e-18
<https://identifiers.org/wikipathways/WP5112_r119153>	WP5112	Familial hyperlipidemia type 5	10	1	5.63675684376111e-18
<https://identifiers.org/wikipathways/WP678_r116938>	WP678	Arachidonate epoxygenase / epoxide hydrolase	10	1	5.63675684376111e-18
<https://identifiers.org/wikipathways/WP1531_r118354>	WP1531	Vitamin D metabolism	9	1	2.51399355231746e-16
<https://identifiers.org/wikipathways/WP1602_r117165>	WP1602	Nicotine effect on dopaminergic neurons	9	1	2.51399355231746e-16
<https://identifiers.org/wikipathways/WP2431_r120812>	WP2431	Spinal cord injury	9	1	2.51399355231746e-16
<https://identifiers.org/wikipathways/WP2435_r120750>	WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	9	1	2.51399355231746e-16
<https://identifiers.org/wikipathways/WP3585_r106742>	WP3585	Cytosine methylation	9	1	2.51399355231746e-16
<https://identifiers.org/wikipathways/WP3680_r117651>	WP3680	Physico-chemical features and toxicity-associated pathways	9	1	2.51399355231746e-16
<https://identifiers.org/wikipathways/WP2513_r119820>	WP2513	Nanoparticle triggered regulated necrosis	8	1	1.24303014531253e-14
<https://identifiers.org/wikipathways/WP4233_r117644>	WP4233	Acrylamide biotransformation and exposure biomarkers	8	1	1.24303014531253e-14
<https://identifiers.org/wikipathways/WP4589_r119266>	WP4589	Major receptors targeted by epinephrine and norepinephrine	8	1	1.24303014531253e-14
<https://identifiers.org/wikipathways/WP4966_r112070>	WP4966	Fluoroacetic acid toxicity	8	1	1.24303014531253e-14
<https://identifiers.org/wikipathways/WP5110_r120392>	WP5110	Familial hyperlipidemia type 3	8	1	1.24303014531253e-14
<https://identifiers.org/wikipathways/WP5143_r120629>	WP5143	GDNF signaling	8	1	1.24303014531253e-14
<https://identifiers.org/wikipathways/WP4487_r102376>	WP4487	Ophthalmate biosynthesis in hepatocytes	7	1	6.89881730648451e-13
<https://identifiers.org/wikipathways/WP500_r121748>	WP500	Glycogen synthesis and degradation	7	1	6.89881730648451e-13
<https://identifiers.org/wikipathways/WP5113_r119486>	WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	7	1	6.89881730648451e-13
<https://identifiers.org/wikipathways/WP4658_r119261>	WP4658	Small cell lung cancer	6	1	4.36596580967519e-11
<https://identifiers.org/wikipathways/WP3627_r119388>	WP3627	Gut-liver indole metabolism 	5	1	3.21626147979406e-09
<https://identifiers.org/wikipathways/WP4341_r122900>	WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	5	1	3.21626147979406e-09
<https://identifiers.org/wikipathways/WP4522_r119310>	WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	5	1	3.21626147979406e-09
<https://identifiers.org/wikipathways/WP4674_r117748>	WP4674	Head and neck squamous cell carcinoma	5	1	3.21626147979406e-09
<https://identifiers.org/wikipathways/WP51_r116716>	WP51	Regulation of actin cytoskeleton	5	1	3.21626147979406e-09
<https://identifiers.org/wikipathways/WP1530_r118120>	WP1530	miRNA regulation of DNA damage response	4	1	2.83674262517836e-07
<https://identifiers.org/wikipathways/WP1584_r122869>	WP1584	Type II diabetes mellitus	4	1	2.83674262517836e-07
<https://identifiers.org/wikipathways/WP206_r117723>	WP206	Fatty acid omega-oxidation	4	1	2.83674262517836e-07
<https://identifiers.org/wikipathways/WP2371_r119919>	WP2371	Parkinson's disease pathway	4	1	2.83674262517836e-07
<https://identifiers.org/wikipathways/WP3301_r120029>	WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	4	1	2.83674262517836e-07
<https://identifiers.org/wikipathways/WP4389_r116629>	WP4389	Bile acids synthesis and enterohepatic circulation 	4	1	2.83674262517836e-07
<https://identifiers.org/wikipathways/WP4942_r115789>	WP4942	15q13.3 copy number variation syndrome	4	1	2.83674262517836e-07
<https://identifiers.org/wikipathways/WP5055_r122621>	WP5055	Burn wound healing	4	1	2.83674262517836e-07
<https://identifiers.org/wikipathways/WP707_r116541>	WP707	DNA damage response	4	1	2.83674262517836e-07
<https://identifiers.org/wikipathways/WP722_r120570>	WP722	Serotonin HTR1 group and FOS pathway	4	1	2.83674262517836e-07
<https://identifiers.org/wikipathways/WP231_r120699>	WP231	TNF-alpha signaling pathway	3	1	3.1204168876962e-05
<https://identifiers.org/wikipathways/WP3998_r119303>	WP3998	Prader-Willi and Angelman syndrome	3	1	3.1204168876962e-05
<https://identifiers.org/wikipathways/WP4216_r119088>	WP4216	Chromosomal and microsatellite instability in colorectal cancer 	3	1	3.1204168876962e-05
<https://identifiers.org/wikipathways/WP4241_r106520>	WP4241	Type 2 papillary renal cell carcinoma	3	1	3.1204168876962e-05
<https://identifiers.org/wikipathways/WP5097_r119075>	WP5097	CCL18 signaling pathway	3	1	3.1204168876962e-05
<https://identifiers.org/wikipathways/WP732_r120591>	WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	3	1	3.1204168876962e-05
<https://identifiers.org/wikipathways/WP3944_r120596>	WP3944	Serotonin and anxiety-related events	2	1	0.00456621004566207
<https://identifiers.org/wikipathways/WP4482_r121703>	WP4482	Vitamin D in inflammatory diseases	2	1	0.00456621004566207
<https://identifiers.org/wikipathways/WP4483_r107927>	WP4483	Relationship between inflammation, COX-2 and EGFR	2	1	0.00456621004566207
<https://identifiers.org/wikipathways/WP734_r117826>	WP734	Serotonin receptor 4/6/7 and NR3C signaling	2	1	0.00456621004566207
<https://identifiers.org/wikipathways/WP3853_r120593>	WP3853	ERK pathway in Huntington's disease	1	1	1
<https://identifiers.org/wikipathways/WP4462_r102079>	WP4462	Platelet-mediated interactions with vascular and circulating cells	1	1	1
<https://identifiers.org/wikipathways/WP733_r120590>	WP733	Serotonin receptor 2 and STAT3 signaling	1	1	1
